A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination

NCT06448364 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic business decision

Conditions

Advanced or Metastatic Solid Tumors
Non-Small Cell Lung Cancer
Colorectal Cancer
Urothelial Cancer
Melanoma

Interventions

BIOLOGICAL: PF-07329640
BIOLOGICAL: sasanlimab
BIOLOGICAL: bevacizumab

Sponsor

Pfizer